News Flash: Brad Wahle Joins Attentive
Feb 7, 2025
2 minutes Read
General
Attentive Science is thrilled to welcome Brad Wahle, M.S., DABT as our new Associate Director of Toxicology! With a distinguished career spanning 36 years of preclinical toxicology, Ag Chem toxicology, safety assessment and regulatory strategy, Brad brings invaluable expertise to our growing team.
A Leader in Toxicology and Regulatory Strategy
Brad is a board-certified toxicologist (DABT) with extensive experience in preclinical drug development, IND-and NDA-enabling toxicology and pharmacology studies, and regulatory submissions. His career has encompassed pivotal roles in both industry and research organizations, making him a strategic addition to Attentive Science. His deep knowledge of preclinical safety evaluation and commitment to scientific excellence align seamlessly with our mission to deliver high-quality, tailored toxicology solutions.
A Passion for Innovation and Mentorship
Beyond his impressive scientific credentials, Brad is known for his mentorship and leadership in the field of toxicology. His dedication to fostering the next generation of scientists and his contributions to regulatory science make him a valuable asset to our clients and team.
Driving Excellence in Toxicology Studies
As Associate Director of Toxicology, Brad will lead our efforts in study design, execution, and regulatory compliance to ensure the highest standards in preclinical safety assessment. His expertise will further strengthen Attentive Science’s commitment to precision, efficiency, and scientific rigor in toxicology studies.
A Word from Brad Wahle
"I am very excited to join Attentive Science and contribute to its mission of delivering top-tier toxicology solutions. I look forward to working side by side with this talented team and supporting our clients in advancing their research. I also greatly appreciate the opportunity to help guide our future leaders in toxicology." – Brad Wahle, M.S., DABT
Join us in welcoming Brad to the Attentive Science team! We’re excited for the impact he will make in advancing our mission and supporting our clients with cutting-edge toxicology solutions.
Social Networks
Tags
Related Blogs
Lab Technicians: The Unsung Heroes Driving Research Success
At Attentive Science, our laboratory technicians are more than technical experts; they are collaborators and real-time problem-solvers
2 mins read
Feb 5, 2026
The Future of CROs: Not AI vs Humans, But AI With Humans.
As 2025 closed, one question dominated life sciences: Will artificial intelligence (AI) replace humans in drug development?
3 mins read
Jan 12, 2026
News Flash: Dr. Basel Assaf Joins Attentive Science Limited
Attentive Science is proud to welcome Dr. Basel Assaf, BVSc, PhD, DACVP, DABT, FIATP as our new Vice President of Toxicology and Pathology.
2 mins read
Sep 24, 2025
Attentive Science Welcomes Thomas O'Neill
We are thrilled to welcome Thomas O’Neill to Attentive Science as our Executive Vice President of Commercial Services and Client Relations.
2 mins read
Mar 11, 2025